(Q43664084)

25 November 2017

title

Efficacy of single-dose intravenous dolasetron versus ondansetron in the prevention of postoperative nausea and vomiting (English)

1 reference

postoperative nausea and vomiting

25 November 2017

main subject

0 references

author name string

Walker JB

series ordinal

1

1 reference

25 November 2017

publication date

1 June 2001

1 reference

25 November 2017

published in

Clinical Therapeutics

1 reference

25 November 2017

volume

23

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

932-938

1 reference

ASHP Therapeutic Guidelines on the Pharmacologic Management of Nausea and Vomiting in Adult and Pediatric Patients Receiving Chemotherapy or Radiation Therapy or Undergoing Surgery

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

Postoperative nausea and vomiting. Its etiology, treatment, and prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

Prevention and treatment of postoperative nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

Risk factors for postoperative nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

Impact of postoperative nausea and vomiting in the surgical setting

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

Antiemetic Efficacy of Ondansetron After Outpatient Laparoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

Single dose intravenous ondansetron in the prevention of postoperative nausea and vomiting.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

Single dose intravenous ondansetron for the 24-hour treatment of postoperative nausea and vomiting.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

Treatment of postoperative nausea and vomiting with ondansetron: a randomized, double-blind comparison with placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

A comparison of the costs and efficacy of ondansetron versus dolasetron for antiemetic prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

Surrogate outcomes: meaningful not!

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

Antiemetic prophylaxis does not improve outcomes after outpatient surgery when compared to symptomatic treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980080-1

7 January 2021

10.1016/S0149-2918(01)80080-1

Identifiers

DOI

1 reference

25 November 2017

1 reference